MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma
- 1 February 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (2) , 239-246
- https://doi.org/10.1016/j.ygyno.2005.08.046
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic responseGynecologic Oncology, 2004
- Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to CisplatinJournal of Investigative Dermatology, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Up–Regulation of Basolateral Multidrug Resistance Protein 3 (Mrp3) in Cholestatic Rat LiverHepatology, 2001
- Identification of the Apical Membrane-targeting Signal of the Multidrug Resistance-associated Protein 2 (MRP2/cMOAT)Journal of Biological Chemistry, 2001
- Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathioneBiochemical Journal, 1999
- Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.Journal of Clinical Investigation, 1998
- Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein GeneScience, 1996
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Basement membrane complexes with biological activityBiochemistry, 1986